The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptides

Posted by
  The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptides Abstract Mesobuthus martensii , the source species of the traditional Chinese medicine “Quanxie”, has long been utilized for its therapeutic properties. Venom peptides are recognized as the major active molecular basis of these pharmacological activities. Despite this, their development as therapeutic agents remains poorly explored. In this study, we performed an integrated multi-omics investigation to systematically explore the venom peptides of Mesobuthus martensii . We generated a chromosome-level genome assembly of Mesobuthus martensii using third-generation sequencing technologies, yielding a genome size of 1.08 Gb with a contig N50 of 46.46 Mb. Integrated genomic and transcriptomic analyses led to the identification of 51 putative novel venom peptide candidates. From the broader venom peptide set, five lysine- and arginine-rich candidates were select...

Diagnostic and therapeutic challenges into snakebite-induced thrombotic microangiopathy: a case report and review of the literature

Posted by

 

Image Credit: Luis A. Roque, Aracnido Taxonomy

Diagnostic and therapeutic challenges into snakebite-induced thrombotic microangiopathy: a case report and review of the literature

Abstract

Background

Snakebite envenomation is a significant global health issue, with India accounting for a substantial number of cases, particularly in rural areas. Venom-induced consumption coagulopathy is a common complication; however, thrombotic microangiopathy remains rare and not well understood. Thrombotic microangiopathy is characterized by microvascular thrombosis, microangiopathic hemolytic anemia, thrombocytopenia, and organ dysfunction. Understanding the pathophysiological differences in snakebite-induced thrombotic microangiopathy is critical for optimizing treatment and outcomes.

Case presentation

We report a case of snakebite-induced thrombotic microangiopathy in a 22-year-old male individual from eastern India who presented with severe thrombocytopenia, acute kidney injury, and neurological deficits. Laboratory investigations revealed schistocytes, elevated lactate dehydrogenase levels, and a PLASMIC score of 6, suggesting thrombotic thrombocytopenic purpura as a subtype of thrombotic microangiopathy. The patient was treated with plasma exchange therapy and supportive measures, including hemodialysis. Initial neurological deterioration, compounded by cerebral edema, necessitated mechanical ventilation. Over time, the patient’s condition improved, and he was discharged on day 42 with recommendations for regular nephrology follow-up.

Conclusion

Snakebite-induced thrombotic microangiopathy may differ from classical thrombocytopenic purpura, potentially involving venom-mediated Von Willebrand factor activation without severe ADAMTS13 deficiency. The use of platelet transfusions before referral may have worsened microthrombus formation and neurological symptoms. This case underscores the need for early recognition of thrombotic microangiopathy in patients who experienced snakebite presenting with thrombocytopenia and microangiopathic hemolytic anemia, even with normal coagulation parameters. Further research is essential to refine diagnostic and management strategies, including cautious platelet transfusion use, to improve outcomes in such complex cases.

Panda, S., Majhi, K., Biswas, T. et al. Diagnostic and therapeutic challenges into snakebite-induced thrombotic microangiopathy: a case report and review of the literature. J Med Case Reports (2026). https://doi.org/10.1186/s13256-025-05804-z